Global Metastatic Bone Disease Market Research Report 2023

Report ID: 2009555 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metastatic Bone Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Medication
        1.2.3 Radiation Therapy
        1.2.4 Surgical Intervention
        1.2.5 Tumor Ablation Therapy
    1.3 Market by Application
        1.3.1 Global Metastatic Bone Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Metastatic Bone Disease Market Perspective (2017-2028)
    2.2 Metastatic Bone Disease Growth Trends by Region
        2.2.1 Metastatic Bone Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Metastatic Bone Disease Historic Market Size by Region (2017-2022)
        2.2.3 Metastatic Bone Disease Forecasted Market Size by Region (2023-2028)
    2.3 Metastatic Bone Disease Market Dynamics
        2.3.1 Metastatic Bone Disease Industry Trends
        2.3.2 Metastatic Bone Disease Market Drivers
        2.3.3 Metastatic Bone Disease Market Challenges
        2.3.4 Metastatic Bone Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Metastatic Bone Disease Players by Revenue
        3.1.1 Global Top Metastatic Bone Disease Players by Revenue (2017-2022)
        3.1.2 Global Metastatic Bone Disease Revenue Market Share by Players (2017-2022)
    3.2 Global Metastatic Bone Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Metastatic Bone Disease Revenue
    3.4 Global Metastatic Bone Disease Market Concentration Ratio
        3.4.1 Global Metastatic Bone Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metastatic Bone Disease Revenue in 2021
    3.5 Metastatic Bone Disease Key Players Head office and Area Served
    3.6 Key Players Metastatic Bone Disease Product Solution and Service
    3.7 Date of Enter into Metastatic Bone Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Bone Disease Breakdown Data by Type
    4.1 Global Metastatic Bone Disease Historic Market Size by Type (2017-2022)
    4.2 Global Metastatic Bone Disease Forecasted Market Size by Type (2023-2028)
5 Metastatic Bone Disease Breakdown Data by Application
    5.1 Global Metastatic Bone Disease Historic Market Size by Application (2017-2022)
    5.2 Global Metastatic Bone Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Metastatic Bone Disease Market Size (2017-2028)
    6.2 North America Metastatic Bone Disease Market Size by Country (2017-2022)
    6.3 North America Metastatic Bone Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Metastatic Bone Disease Market Size (2017-2028)
    7.2 Europe Metastatic Bone Disease Market Size by Country (2017-2022)
    7.3 Europe Metastatic Bone Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Metastatic Bone Disease Market Size (2017-2028)
    8.2 Asia-Pacific Metastatic Bone Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific Metastatic Bone Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Metastatic Bone Disease Market Size (2017-2028)
    9.2 Latin America Metastatic Bone Disease Market Size by Country (2017-2022)
    9.3 Latin America Metastatic Bone Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Metastatic Bone Disease Market Size (2017-2028)
    10.2 Middle East & Africa Metastatic Bone Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa Metastatic Bone Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Metastatic Bone Disease Introduction
        11.1.4 Amgen Revenue in Metastatic Bone Disease Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 Merck & Co
        11.2.1 Merck & Co Company Detail
        11.2.2 Merck & Co Business Overview
        11.2.3 Merck & Co Metastatic Bone Disease Introduction
        11.2.4 Merck & Co Revenue in Metastatic Bone Disease Business (2017-2022)
        11.2.5 Merck & Co Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Metastatic Bone Disease Introduction
        11.3.4 Roche Revenue in Metastatic Bone Disease Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Metastatic Bone Disease Introduction
        11.4.4 Novartis Revenue in Metastatic Bone Disease Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Detail
        11.5.2 Eli Lilly and Company Business Overview
        11.5.3 Eli Lilly and Company Metastatic Bone Disease Introduction
        11.5.4 Eli Lilly and Company Revenue in Metastatic Bone Disease Business (2017-2022)
        11.5.5 Eli Lilly and Company Recent Development
    11.6 Bayer
        11.6.1 Bayer Company Detail
        11.6.2 Bayer Business Overview
        11.6.3 Bayer Metastatic Bone Disease Introduction
        11.6.4 Bayer Revenue in Metastatic Bone Disease Business (2017-2022)
        11.6.5 Bayer Recent Development
    11.7 Fresenius Kabi
        11.7.1 Fresenius Kabi Company Detail
        11.7.2 Fresenius Kabi Business Overview
        11.7.3 Fresenius Kabi Metastatic Bone Disease Introduction
        11.7.4 Fresenius Kabi Revenue in Metastatic Bone Disease Business (2017-2022)
        11.7.5 Fresenius Kabi Recent Development
    11.8 BTG plc
        11.8.1 BTG plc Company Detail
        11.8.2 BTG plc Business Overview
        11.8.3 BTG plc Metastatic Bone Disease Introduction
        11.8.4 BTG plc Revenue in Metastatic Bone Disease Business (2017-2022)
        11.8.5 BTG plc Recent Development
    11.9 Boston Scientific
        11.9.1 Boston Scientific Company Detail
        11.9.2 Boston Scientific Business Overview
        11.9.3 Boston Scientific Metastatic Bone Disease Introduction
        11.9.4 Boston Scientific Revenue in Metastatic Bone Disease Business (2017-2022)
        11.9.5 Boston Scientific Recent Development
    11.10 Medtronic
        11.10.1 Medtronic Company Detail
        11.10.2 Medtronic Business Overview
        11.10.3 Medtronic Metastatic Bone Disease Introduction
        11.10.4 Medtronic Revenue in Metastatic Bone Disease Business (2017-2022)
        11.10.5 Medtronic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Metastatic Bone Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Medication
    Table 3. Key Players of Radiation Therapy
    Table 4. Key Players of Surgical Intervention
    Table 5. Key Players of Tumor Ablation Therapy
    Table 6. Global Metastatic Bone Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Metastatic Bone Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Metastatic Bone Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Metastatic Bone Disease Market Share by Region (2017-2022)
    Table 10. Global Metastatic Bone Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Metastatic Bone Disease Market Share by Region (2023-2028)
    Table 12. Metastatic Bone Disease Market Trends
    Table 13. Metastatic Bone Disease Market Drivers
    Table 14. Metastatic Bone Disease Market Challenges
    Table 15. Metastatic Bone Disease Market Restraints
    Table 16. Global Metastatic Bone Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Metastatic Bone Disease Market Share by Players (2017-2022)
    Table 18. Global Top Metastatic Bone Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Bone Disease as of 2021)
    Table 19. Ranking of Global Top Metastatic Bone Disease Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Metastatic Bone Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Metastatic Bone Disease Product Solution and Service
    Table 23. Date of Enter into Metastatic Bone Disease Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Metastatic Bone Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Metastatic Bone Disease Revenue Market Share by Type (2017-2022)
    Table 27. Global Metastatic Bone Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Metastatic Bone Disease Revenue Market Share by Type (2023-2028)
    Table 29. Global Metastatic Bone Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Metastatic Bone Disease Revenue Market Share by Application (2017-2022)
    Table 31. Global Metastatic Bone Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Metastatic Bone Disease Revenue Market Share by Application (2023-2028)
    Table 33. North America Metastatic Bone Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Metastatic Bone Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Metastatic Bone Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Metastatic Bone Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Metastatic Bone Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Metastatic Bone Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Metastatic Bone Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Metastatic Bone Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Metastatic Bone Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Metastatic Bone Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Amgen Company Detail
    Table 44. Amgen Business Overview
    Table 45. Amgen Metastatic Bone Disease Product
    Table 46. Amgen Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 47. Amgen Recent Development
    Table 48. Merck & Co Company Detail
    Table 49. Merck & Co Business Overview
    Table 50. Merck & Co Metastatic Bone Disease Product
    Table 51. Merck & Co Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 52. Merck & Co Recent Development
    Table 53. Roche Company Detail
    Table 54. Roche Business Overview
    Table 55. Roche Metastatic Bone Disease Product
    Table 56. Roche Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 57. Roche Recent Development
    Table 58. Novartis Company Detail
    Table 59. Novartis Business Overview
    Table 60. Novartis Metastatic Bone Disease Product
    Table 61. Novartis Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 62. Novartis Recent Development
    Table 63. Eli Lilly and Company Company Detail
    Table 64. Eli Lilly and Company Business Overview
    Table 65. Eli Lilly and Company Metastatic Bone Disease Product
    Table 66. Eli Lilly and Company Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 67. Eli Lilly and Company Recent Development
    Table 68. Bayer Company Detail
    Table 69. Bayer Business Overview
    Table 70. Bayer Metastatic Bone Disease Product
    Table 71. Bayer Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 72. Bayer Recent Development
    Table 73. Fresenius Kabi Company Detail
    Table 74. Fresenius Kabi Business Overview
    Table 75. Fresenius Kabi Metastatic Bone Disease Product
    Table 76. Fresenius Kabi Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 77. Fresenius Kabi Recent Development
    Table 78. BTG plc Company Detail
    Table 79. BTG plc Business Overview
    Table 80. BTG plc Metastatic Bone Disease Product
    Table 81. BTG plc Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 82. BTG plc Recent Development
    Table 83. Boston Scientific Company Detail
    Table 84. Boston Scientific Business Overview
    Table 85. Boston Scientific Metastatic Bone Disease Product
    Table 86. Boston Scientific Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 87. Boston Scientific Recent Development
    Table 88. Medtronic Company Detail
    Table 89. Medtronic Business Overview
    Table 90. Medtronic Metastatic Bone Disease Product
    Table 91. Medtronic Revenue in Metastatic Bone Disease Business (2017-2022) & (US$ Million)
    Table 92. Medtronic Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metastatic Bone Disease Market Share by Type: 2021 VS 2028
    Figure 2. Medication Features
    Figure 3. Radiation Therapy Features
    Figure 4. Surgical Intervention Features
    Figure 5. Tumor Ablation Therapy Features
    Figure 6. Global Metastatic Bone Disease Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Metastatic Bone Disease Report Years Considered
    Figure 11. Global Metastatic Bone Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Metastatic Bone Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Metastatic Bone Disease Market Share by Region: 2021 VS 2028
    Figure 14. Global Metastatic Bone Disease Market Share by Players in 2021
    Figure 15. Global Top Metastatic Bone Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Bone Disease as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Metastatic Bone Disease Revenue in 2021
    Figure 17. North America Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Metastatic Bone Disease Market Share by Country (2017-2028)
    Figure 19. United States Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Metastatic Bone Disease Market Share by Country (2017-2028)
    Figure 23. Germany Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Metastatic Bone Disease Market Share by Region (2017-2028)
    Figure 31. China Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Metastatic Bone Disease Market Share by Country (2017-2028)
    Figure 39. Mexico Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Metastatic Bone Disease Market Share by Country (2017-2028)
    Figure 43. Turkey Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Metastatic Bone Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Amgen Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 46. Merck & Co Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 47. Roche Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 48. Novartis Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 49. Eli Lilly and Company Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 50. Bayer Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 51. Fresenius Kabi Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 52. BTG plc Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 53. Boston Scientific Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 54. Medtronic Revenue Growth Rate in Metastatic Bone Disease Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Merck & Co
Roche
Novartis
Eli Lilly and Company
Bayer
Fresenius Kabi
BTG plc
Boston Scientific
Medtronic
Frequently Asked Questions
Metastatic Bone Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metastatic Bone Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metastatic Bone Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports